Your new experience awaits. Try the new design now and help us make it even better

METHODS article

Front. Bioeng. Biotechnol.

Sec. Biomaterials

This article is part of the Research TopicDevelopment of novel engineered biomaterials with clinical translation prospects for chronic disease theranosticsView all 3 articles

A novel agarose-free, standardized generation and versatile ECM characterization of decellularized scaffolds from normal and fibrotic human lung tissue

Provisionally accepted
Eike  B. PreußEike B. Preuß1*Lara-Jasmin  SchröderLara-Jasmin Schröder1Charlotte  HähnerCharlotte Hähner1Jérôme  A. von BandemerJérôme A. von Bandemer1Christopher  WerleinChristopher Werlein1Edith  K. J. SchwarzEdith K. J. Schwarz1Stephanie  SchubertStephanie Schubert1Holger  SchlüterHolger Schlüter2Matt  ThomasMatt Thomas2Danny  JonigkDanny Jonigk3Jan  C. KampJan C. Kamp1,4Mark  KuehnelMark Kuehnel3
  • 1Medizinische Hochschule Hannover, Hanover, Germany
  • 2Boehringer Ingelheim, Biberach, Germany
  • 3Universitatsklinikum Aachen, Aachen, Germany
  • 4Department of Respiratory Medicine, Hannover Medical School, Hannover, Germany

The final, formatted version of the article will be published soon.

Background: The extracellular matrix (ECM) is a key regulator of tissue homeostasis and remodeling in interstitial lung diseases (ILD) such as idiopathic pulmonary fibrosis (IPF) and fibrotic hypersensitivity pneumonitis (FHP). Decellularized lung scaffolds provide a physiologically relevant platform for studying cell-matrix interactions but generating structurally intact scaffolds from fibrotic human lungs remains challenging. Many existing protocols struggle with either insufficient removal of the cells or significant disruption of certain ECM components. In addition, all of them rely on agarose-embedding for the production of thin lung slices. Methods:Tissue samples were decellularized using apoptosis inducers (Camptothecin, Raptinal) and a mild detergent (SB-10). Standardized decellularized lung scaffolds (SDLS) were generated using a gelatin-based temporary cutting support structure, which is completely removable prior to recellularization. Decellularization and preservation of the ECM was validated by DAPI nuclear counts and semi-quantitative image analysis of collagen (picro-sirius red under polarization) and elastin (elastic Verhoeff-Van Gieson (EVG)). For functional testing, SDLS were repopulated with primary human lung fibroblasts (CD90⁺CD31⁻CD45⁻) and assessed for colonization, viability (WST-1 assay), and cytotoxicity (LDH assay). Results: The protocol removed all nuclei (>99.8%) in both fibrotic and non-fibrotic lung tissue while preserving structural integrity and the major ECM components (collagen and elastin). The novel semi-quantitative analysis proved to be accurate and versatile for the analysis of multiple ECM components within one sample. Overall, both Collagen (fresh 15.5% ± 4.3 vs decellularized 16.7% ± 4.4) and elastin (fresh 10.0% ± 3.7 vs decellularized 9.8% ± 3.4) remained stable post-decellularization. Fibroblasts successfully colonized SDLS, with non-fibrotic scaffolds showing pronounced contraction, whereas fibrotic scaffolds retained their dimensions. Even though fibroblasts seeded on SDLS showed significantly lower viability than those seeded on plastic plates, cytotoxicity one day after repopulation was not increased and remained acceptable. Conclusion:We present a reproducible, agarose-free, apoptosis-assisted method for the generation of residue-free and standardized decellularized lung scaffolds from normal and fibrotic human tissue. The novel semi-quantitative histological analysis allows the investigation of multiple ECM components from a single sample. The SDLS platform preserves key ECM components and supports controlled recellularization enabling physiologically relevant studies of matrix-cell interactions and therapeutic screening in ILD models.

Keywords: agarose-free decellularization, decellularized humanlung scaffolds, Extracellular Matrix, Hypersensitivity pneumonitis, Idiopathic Pulmonary Fibrosis, Recellularization, semi-quantitative image analysis

Received: 22 Dec 2025; Accepted: 13 Feb 2026.

Copyright: © 2026 Preuß, Schröder, Hähner, von Bandemer, Werlein, Schwarz, Schubert, Schlüter, Thomas, Jonigk, Kamp and Kuehnel. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Eike B. Preuß

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.